Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (71-80 of 395) with videos related to

Pageof 40
Sort By:
Nature Reviews. Rheumatology|September 1, 2017
Rheumatoid arthritis: Remission - keeping the patient experience front and centreLilian H D van Tuyl, Maarten Boers
The Journal of Rheumatology|April 3, 2013
Patient-reported remission in rheumatoid arthritisLilian H D van Tuyl, Maarten Boers
Nature Reviews. Rheumatology|March 22, 2018
The controversy of using PGA to define remission in RALilian H D van Tuyl, Maarten Boers
Nature Reviews. Rheumatology|September 2, 2015
Patient-reported outcomes in core domain sets for rheumatic diseasesLilian H D van Tuyl, Maarten Boers
The Journal of Rheumatology|August 3, 2011
Examining the similarities and differences of OMERACT core sets using the ICF: first step towards an improved domain specification and development of an item pool to measure functioning and healthReuben Escorpizo, Maarten Boers, Gerold Stucki, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studiesMaya H Buch, Walter P Maksymowych, Maarten Boers
The Journal of Rheumatology|May 8, 2003
Deriving an operational definition of low disease activity state in rheumatoid arthritisMaarten Boers, Jennifer J Anderson, David T Felson
The Journal of Rheumatology|March 4, 2014
Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome setsLeanne Idzerda, Tamara Rader, Peter Tugwell, et al.
The Journal of Rheumatology|May 5, 2007
Rationale and strategies for reevaluating the ACR20David T Felson, Daniel E Furst, Maarten Boers
The Journal of Rheumatology|August 13, 2009
OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trialsPeter Tugwell, Maarten Boers, Vibeke Strand, et al.
Pageof 40

Showing results (71-80 of 395) with videos related to

Sort By:
Pageof 40
Nature Reviews. Rheumatology|September 1, 2017
Rheumatoid arthritis: Remission - keeping the patient experience front and centreLilian H D van Tuyl, Maarten Boers
The Journal of Rheumatology|April 3, 2013
Patient-reported remission in rheumatoid arthritisLilian H D van Tuyl, Maarten Boers
Nature Reviews. Rheumatology|March 22, 2018
The controversy of using PGA to define remission in RALilian H D van Tuyl, Maarten Boers
Nature Reviews. Rheumatology|September 2, 2015
Patient-reported outcomes in core domain sets for rheumatic diseasesLilian H D van Tuyl, Maarten Boers
The Journal of Rheumatology|August 3, 2011
Examining the similarities and differences of OMERACT core sets using the ICF: first step towards an improved domain specification and development of an item pool to measure functioning and healthReuben Escorpizo, Maarten Boers, Gerold Stucki, et al.
Annals of the Rheumatic Diseases|January 14, 2022
Managing the selection of placebo group switched to experimental treatment group in post-randomised controlled trial extension studiesMaya H Buch, Walter P Maksymowych, Maarten Boers
The Journal of Rheumatology|May 8, 2003
Deriving an operational definition of low disease activity state in rheumatoid arthritisMaarten Boers, Jennifer J Anderson, David T Felson
The Journal of Rheumatology|March 4, 2014
Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome setsLeanne Idzerda, Tamara Rader, Peter Tugwell, et al.
The Journal of Rheumatology|May 5, 2007
Rationale and strategies for reevaluating the ACR20David T Felson, Daniel E Furst, Maarten Boers
The Journal of Rheumatology|August 13, 2009
OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trialsPeter Tugwell, Maarten Boers, Vibeke Strand, et al.
Pageof 40